In late June 2009, Steve Jobs returned to work as Apple Inc.’s (AAPL) CEO. His return comes following a surprise five-month hiatus, which Jobs claimed he needed as the result of “complex” health issues. We now know he had a liver transplant at a Memphis hospital in April. Speculation about Jobs’s health and the future of Apple has swirled for months, ever since he appeared gaunt at public appearances last summer. Given his and his company’s prior dissembling about his health, can we now trust assurances that he is recovering well? And what does this all mean for Apple and its competitors? Realistically, Steve Jobs’s return as CEO probably means very little. While Jobs has been the driving force behind Apple for most of its history, he has created a company that is, in many ways, a clone of himself. Every Apple employee, from management on down, understands that the...